Compounds > (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide
Page last updated: 2024-09-04

(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and Flushing

(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide has been researched along with Flushing in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clifton, HL; Inceoglu, B; Ma, L; Schaefer, S; Zheng, J1

Other Studies

1 other study(ies) available for (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and Flushing

ArticleYear
TRPV1 channels are involved in niacin-induced cutaneous vasodilation in mice.
    Journal of cardiovascular pharmacology, 2015, Volume: 65, Issue:2

    Topics: Acrylamides; Animals; Bridged Bicyclo Compounds, Heterocyclic; Capsaicin; Disease Models, Animal; Flushing; Mice; Mice, Knockout; Niacin; Sensory System Agents; TRPV Cation Channels; Vasodilation; Vasodilator Agents

2015